RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-6.87%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$6.23B
AUM Growth
-$401M
(-6.1%)
Cap. Flow
+$768M
Cap. Flow
% of AUM
12.33%
Top 10 Holdings %
Top 10 Hldgs %
46.21%
Holding
101
New
19
Increased
9
Reduced
3
Closed
9
Top Buys
Top Sells
| 1 |
Novavax
NVAX
|
$93.9M |
| 2 |
Adverum Biotechnologies
ADVM
|
$92.3M |
| 3 |
IGMS
IGM Biosciences
IGMS
|
$75.4M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$52.4M |
| 5 |
TG Therapeutics
TGTX
|
$50.2M |
Sector Composition
| 1 | Healthcare | 97.5% |
| 2 | Financials | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
ProQR Therapeutics
PRQR
$256M
| – | – |
-2,117,669
| Closed | -$14M |
|